Literature DB >> 24461902

Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis.

Jose Luis López-Campos1, Miguel Ruiz-Ramos2, Joan B Soriano3.   

Abstract

BACKGROUND: Findings from studies done over the past 20 years suggest that mortality from chronic obstructive pulmonary disease (COPD) is decreasing worldwide, but little information is available for trends in Europe. We aimed to describe COPD mortality trends by sex and calendar year for the period of 1994 to 2010.
METHODS: We extracted data for COPD deaths between 1994 and 2010 in the 27 countries in the European Union (EU) from the statistical office of the EU (Eurostat), using the International Classification of Diseases 10 (ICD-10) codes J40-J44 and J47. We estimated age-standardised mortality rates (ASR), and analysed data using joinpoint regression, for women and men in the EU overall and by individual country for each year. We used the standard European population as the reference and present our findings as deaths per 100,000 person-years. We compared findings for each country with the EU average by calculating standardised rate ratios (SRR) and 95% CIs.
FINDINGS: Between 1994 and 2010, there were 2,348,184 recorded COPD deaths in the EU. COPD mortality was higher in men than in women throughout the study period in all EU countries. In the EU overall, deaths per 100,000 population decreased in men almost linearly from 90·07 in 1994 to 61·33 in 2010, and in women from 26·99 in 1994 to 25·15 in 2010, representing a narrowing in gender gap over the study period. Several countries had a higher SRR mortality than the EU average-eg, Ireland, Hungary, and Belgium for men and Denmark, the UK, and the Netherlands for women. Our joinpoint regression analysis identified no statistically significant changes in the trend for the whole EU, but several countries had changing trends over the study period. In men, we recorded a 2·56% constant and statistically significant decrease in ASRs in the EU. Five countries had an increase in ASR. Overall, in women, we recorded a 0·76% statistically significant decrease in ASRs. 14 countries had an increase in ASR.
INTERPRETATION: Our findings indicate a downward trend in COPD mortality in Europe between 1994 and 2010. The data also suggest a narrowing of the gap between COPD mortality in men and in women. The wide heterogeneity in mortality rates within European countries could serve as a reference to allow informed policy making. FUNDING: None.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24461902     DOI: 10.1016/S2213-2600(13)70232-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  42 in total

1.  Global and regional trends in COPD mortality, 1990-2010.

Authors:  Peter G J Burney; Jaymini Patel; Roger Newson; Cosetta Minelli; Mohsen Naghavi
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

2.  Trends in mortality from COPD among adults in the United States.

Authors:  Earl S Ford
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

3.  Where Do Chronic Obstructive Pulmonary Disease Patients Die? 8-Year Trend, with Special Focus on Sex-Related Differences.

Authors:  Alberto Fernández-García; Mónica Pérez-Ríos; Cristina Candal-Pedreira; Cristina Represas-Represas; Alberto Fernández-Villar; María Isolina Santiago-Pérez; Julia Rey-Brandariz; Gael Naveira-Barbeito; Alberto Malvar-Pintos; Alberto Ruano-Ravina
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-05-06

4.  Air pollution and respiratory health among diabetic and non-diabetic subjects in Pune, India-results from the Wellcome Trust Genetic Study.

Authors:  Morteza Abdullatif Khafaie; Sundeep Santosh Salvi; Chittaranjan Sakerlal Yajnik; Ajay Ojha; Behzad Khafaie; Sharad Damodar Gore
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-17       Impact factor: 4.223

5.  Temporal trends in smoking and nicotine dependence in relation to co-occurring substance use in the United States, 2005-2016.

Authors:  Yun Wang; Ying Liu; Mary Waldron; Alexandra N Houston-Ludlam; Vivia V McCutcheon; Michael T Lynskey; Pamela A F Madden; Kathleen K Bucholz; Andrew C Heath; Min Lian
Journal:  Drug Alcohol Depend       Date:  2021-07-21       Impact factor: 4.852

6.  Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.

Authors:  Alberto Fernández-Villar; José Luis López-Campos; Cristina Represas Represas; Lucía Marín Barrera; Virginia Leiro Fernández; Cecilia López Ramírez; Ricard Casamor
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-18

7.  What pulmonologists think about the asthma-COPD overlap syndrome.

Authors:  Marc Miravitlles; Bernardino Alcázar; Francisco Javier Alvarez; Teresa Bazús; Myriam Calle; Ciro Casanova; Carolina Cisneros; Juan P de-Torres; Luis M Entrenas; Cristóbal Esteban; Patricia García-Sidro; Borja G Cosio; Arturo Huerta; Milagros Iriberri; José Luis Izquierdo; Antolín López-Viña; José Luis López-Campos; Eva Martínez-Moragón; Luis Pérez de Llano; Miguel Perpiñá; José Antonio Ros; José Serrano; Juan José Soler-Cataluña; Alfons Torrego; Isabel Urrutia; Vicente Plaza
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-15

8.  Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; Alicia Huerta; Manuel Valle; Patricia García-Sidro; Carles Forné; Carlos Crespo; José Luis López-Campos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-16

Review 9.  Clinical Approach to the Therapy of Asthma-COPD Overlap.

Authors:  Diego J Maselli; Megan Hardin; Stephanie A Christenson; Nicola A Hanania; Craig P Hersh; Sandra G Adams; Antonio Anzueto; Jay I Peters; MeiLan K Han; Fernando J Martinez
Journal:  Chest       Date:  2018-08-02       Impact factor: 10.262

10.  Clinical Audits in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Workflow.

Authors:  Jose Luis López-Campos; María Abad Arranz; Carmen Calero Acuña; Fernando Romero Valero; Ruth Ayerbe García; Antonio Hidalgo Molina; Ricardo Ismael Aguilar Pérez-Grovas; Francisco García Gil; Francisco Casas Maldonado; Laura Caballero Ballesteros; María Sánchez Palop; Dolores Pérez-Tejero; Alejandro Segado; Jose Calvo Bonachera; Bárbara Hernández Sierra; Adolfo Doménech; Macarena Arroyo Varela; Francisco González Vargas; Juan Jose Cruz Rueda
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.